FERAGALLI, Beatrice
 Distribuzione geografica
Continente #
NA - Nord America 4.575
AS - Asia 3.232
EU - Europa 2.922
SA - Sud America 611
OC - Oceania 49
AF - Africa 40
Continente sconosciuto - Info sul continente non disponibili 8
AN - Antartide 1
Totale 11.438
Nazione #
US - Stati Uniti d'America 4.485
SG - Singapore 1.335
CN - Cina 858
IE - Irlanda 563
IT - Italia 509
BR - Brasile 505
UA - Ucraina 394
SE - Svezia 361
TR - Turchia 329
GB - Regno Unito 263
VN - Vietnam 214
DE - Germania 213
FR - Francia 176
IN - India 138
RU - Federazione Russa 93
HK - Hong Kong 88
FI - Finlandia 70
ES - Italia 55
AU - Australia 46
CA - Canada 46
AR - Argentina 44
AT - Austria 39
ID - Indonesia 33
PL - Polonia 31
BE - Belgio 30
NL - Olanda 30
JP - Giappone 28
BD - Bangladesh 27
TW - Taiwan 27
EC - Ecuador 25
PT - Portogallo 25
MX - Messico 24
IR - Iran 23
TH - Thailandia 23
KR - Corea 21
MY - Malesia 21
ZA - Sudafrica 18
CZ - Repubblica Ceca 15
IQ - Iraq 13
CO - Colombia 10
PK - Pakistan 10
RO - Romania 10
CH - Svizzera 9
PY - Paraguay 8
CL - Cile 7
EU - Europa 7
UZ - Uzbekistan 7
AE - Emirati Arabi Uniti 6
BG - Bulgaria 6
HR - Croazia 5
IL - Israele 5
PA - Panama 5
VE - Venezuela 5
DZ - Algeria 4
EE - Estonia 4
LT - Lituania 4
UY - Uruguay 4
DO - Repubblica Dominicana 3
EG - Egitto 3
GR - Grecia 3
JM - Giamaica 3
KE - Kenya 3
MA - Marocco 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
OM - Oman 3
SK - Slovacchia (Repubblica Slovacca) 3
TN - Tunisia 3
AZ - Azerbaigian 2
BO - Bolivia 2
DK - Danimarca 2
GT - Guatemala 2
JO - Giordania 2
KW - Kuwait 2
KZ - Kazakistan 2
LU - Lussemburgo 2
ME - Montenegro 2
MM - Myanmar 2
NG - Nigeria 2
PH - Filippine 2
QA - Qatar 2
SC - Seychelles 2
SV - El Salvador 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AQ - Antartide 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CG - Congo 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
HU - Ungheria 1
KG - Kirghizistan 1
KH - Cambogia 1
LK - Sri Lanka 1
MC - Monaco 1
MD - Moldavia 1
NO - Norvegia 1
NP - Nepal 1
PE - Perù 1
PS - Palestinian Territory 1
Totale 11.434
Città #
Singapore 961
Chandler 659
Jacksonville 576
Dublin 547
Princeton 254
Dallas 244
Ashburn 214
Beijing 197
Izmir 166
Nanjing 165
Santa Clara 149
Southend 127
Los Angeles 120
Wilmington 117
Altamura 104
The Dalles 103
New York 87
Ho Chi Minh City 85
Cambridge 83
Ann Arbor 74
Hong Kong 69
Dearborn 67
Nanchang 60
Chieti 56
Hanoi 50
Redondo Beach 49
Boardman 47
Tongling 37
Buffalo 35
São Paulo 35
Kunming 33
Munich 33
Shenyang 31
Hebei 29
Seattle 28
Menlo Park 26
Milan 26
Tianjin 25
Falls Church 24
Catania 23
Brussels 22
Woodbridge 22
Houston 21
Jiaxing 21
Frankfurt am Main 20
Rio de Janeiro 20
Tokyo 20
Washington 20
Denver 19
Santa Pola 19
Chennai 18
Sydney 18
Hangzhou 17
Istanbul 17
Norwalk 17
Vienna 17
Kuala Lumpur 16
Toronto 16
Brooklyn 15
London 15
Shanghai 15
Warsaw 15
Changsha 14
Curitiba 14
Helsinki 14
Pescara 14
Amsterdam 13
Nuremberg 13
Stoke-on-Trent 13
Taichung 13
Calpe 12
Chicago 12
Da Nang 12
Guangzhou 12
Montreal 12
Rome 12
San Jose 12
Taipei 12
Atlanta 11
Johannesburg 11
Manchester 11
Phoenix 11
Ankara 10
Columbus 10
Lanzhou 10
Orem 10
Poplar 10
Bengaluru 9
Guayaquil 9
Waidhofen An Der Ybbs 9
Brno 8
Hefei 8
Jakarta 8
Melbourne 8
Namur 8
New Delhi 8
Pune 8
Redwood City 8
San Francisco 8
Stockholm 8
Totale 6.620
Nome #
Supplementary prevention and management of asthma with quercetin phytosome: a pilot registry 397
Pycnogenol® supplementation prevents inflammation and symptoms in recurrent, non-severe urinary infections 188
Cone beam computed tomography for dental and maxillofacial imaging: technique improvement and low-dose protocols 158
Pulmonary nodule [Il nodulo polmonare] 156
Effects of collagen remodulation with Centella asiatica (Centellicum®) in Dupuytren palmar fibromatosis: a pilot supplement study 154
Effects of different doses of Pycnogenol® on plasma oxidative stress: A pilot, supplement study 150
[Possibility of false negative results in the diagnosis of lung neoplasms with computerized tomography] 148
Aescin and microcirculatory activity. Effects of accessory components on clinical and microcirculatory efficacy. 142
Robuvit® (Quercus robur extract) supplementation in subjects with chronic fatigue syndrome and increased oxidative stress. A pilot registry study 139
Long-haul flights, edema, and thrombotic events: prevention with stockings and Pycnogenol® supplementation (LONFLIT Registry Study). 135
The lung in systemic vasculitis: Radiological patterns and differential diagnosis 133
Biomechanical aspects in late implant failures: Scanning electron microscopy analysis of four clinical cases 131
Moderate, diffuse, somatic muscular pain: Effects of supplementation with a Pycnogenol patch 125
Pycnogenol® and Centella asiatica to prevent asymptomatic atherosclerosis progression in clinical events 125
An open, supplement, registry study Arborvitae (R) for prevention of arthrosis-related pain during exercise 123
Management of Varicose Veins and Chronic Venous Insufficiency in a Comparative Registry with Nine Venoactive Products in Comparison with Stockings 120
Mononucleosis-related fatigue: supplementary management with Robuvit®. 118
Effects of pycnogenol on endothelial dysfunction in borderline hypertensive, hyperlipidemic, and hyperglycemic individuals: the borderline study. 117
Anatomical features of cephalothoracopagus variations: CT and MRI. 116
TECA (Titrated Extract of Centella Asiatica): new microcirculatory, biomolecular, and vascular application in preventive and clinical medicine. A status paper. 114
Management of functional, hepatic damage after chemotherapy with Liverubin (pharma-standard silymarin). 113
Bilberry extracts are not created equal: the role of non anthocyanin fraction. Discovering the "dark side of the force" in a preliminary study 112
Temporary kidney dysfunction: Robuvit® supplementation in initial, transient kidney insufficiency and micro-macro albuminuria 112
Aescin: microcirculatory activity. Effects of accessory components on clinical and microcirculatory efficacy. 110
Pycnogenol® supplementation improves the control of irritable bowel syndrome symptoms. 110
Arterial Thrombosis in ambulatory cancer patients treated with chemotherapy. 110
Thyroid cysts treatment with the sclerosing agent Atossiclerol. Long-term (5 to 15 years) follow-up. 109
Management of mild, primary Raynaud Syndrome: supplementation with Pycnogenol (R) 106
Exploring the concept of vigor and dys-vigor in men of 50-65 years: effects of Robuvit® 106
Management of symptoms, pain and mobility with supplementary managements (including Movardol Forte) in osteoarthrosis: A 6-month, morphology supplement study 105
Supplementation with a new food grade delivery system of Boswellia and Centella in the intervertebral discs registry: The Sager study 105
Activity of some physiological modulators in reducing the side effects of levothyroxine in patients suffering from primary hypothyroidism. 104
Assessment of aortic valve area (AVA) by cardiac magnetic resonance (CMR) imaging in comparison with transthoracic (TTE) and transesophageal echocardiography (TEE) 104
Valutazione dell'area valvolare aortica (AVA): confronto fra risonanza cardiaca (RCM), ecocardiografiatranstoracia (ETT) e transesofagea (ETE) 104
A natural pharma standard supplement formulation to control treatment-related toxicity and oxidative stress in genitourinary cancer: a preliminary study 104
Effectiveness of a novel boswellic acids delivery form (Casperome®) in the management of grade II ankle sprains due to sport trauma - a registry study 104
Behçet syndrome: effects of Pycnogenol® supplementation during regression phases. 104
Supplementary management with Pycnogenol® in Parkinson's disease to prevent cognitive impairment. 104
Supplementation with a lecithin-based delivery form of Boswellia serrata extract (Casperome®) controls symptoms of mild irritable bowel syndrome 101
Improvement of common cold with Pycnogenol®: a Winter registry study. 99
Recurrence of retinal vein thrombosis with Pycnogenol® or Aspirin® supplementation: a registry study 99
Pycnogenolà supplementation improves health risk factors in subjects with metabolic syndrome 99
Prevention of recurrent venous thrombosis and post-thrombotic syndrome. 98
Robuvit®: improvement of fatigue in medical convalescence. 98
Malignant pleural disease 97
Delayed progression of atherosclerosis and cardiovascular events in asymptomatic patients with atherosclerotic plaques; 3-year prevention with the supplementation with Pycnogenol®+Centellicum® 97
Artificial Saliva in Diabetic Xerostomia (ASDIX): Double Blind Trial of Aldiamed® Versus Placebo 96
Interaction study between antiplatelet agents, anticoagulants, diabetic therapy and a novel delivery form of quercetin. 94
Venoruton®: post thrombotic syndrome. Clinical improvement in venous insufficiency (signs and symptoms) with Venoruton®. A five-year, open-registry, efficacy study. 93
Supplementation with Robuvit® in subjects with burnout associated to high oxidative stress 93
Errors in imaging of traumatic injuries 92
7T mMR in the assessment of acute arterial mesenteric ischemia in a rat model 92
Supplementary management of functional, hepatic damage with Liverubin (pharma-standard Silymarin). A 3-month registry. 92
Mirtogenol® supplementation in association with dorzolamide-timolol or latanoprost improves the retinal microcirculation in asymptomatic patients with increased ocular pressure 92
Primary benign back pain: supplementation with Pycnogenol® 92
Incidental venous thromboembolism in ambulatory cancer patients receiving chemotherapy 91
Malignant pleural disease 91
Small-Bowel Neoplasms: Role of MRI Enteroclysis 91
Activity of some physiological modulators in reducing the side effects of levothyroxine in patients suffering from primary hypothyroidism. 90
Ecografia toracica. Diagnosi e tecniche interventistiche 90
Non-small cell lung carcinoma. Early diagnosis: applicability of a screening 90
Pycnogenol®+Centellicum®, post-stent evaluation: prevention of neointima and plaque re-growth 90
Oxidative stress following administration of levothyroxine in subjects suffering from primary hypothyroidism. 89
Radiographic evaluation of mediastinal lines as a diagnostic approach to occult or subtle mediastinal abnormalities. 89
The COFU3 Study. Improvement in cognitive function, attention, mental performance with Pycnogenol® in healthy subjects (55-70) with high oxidative stress 89
Supplementation with Pycnogenol® improves signs and symptoms of menopausal transition. 88
Chronic venous insufficiency and venous microangiopathy: Management with compression and Pycnogenol® 88
Managing ulcerative colitis in remission phase: usefulness of Casperome®, an innovative lecithin-based delivery system of Boswellia serrata extract 87
Prevention of diffuse, minimal lymphatic "retention" with Robuvit®: a concept, supplement registry study 87
Topical formulation of heparin is effective in reducing the symptoms of superficial venous thrombosis: a monocenter, observer-blind, placebo-controlled randomized study. 86
Recurrent retinal vein thrombosis: prevention with Aspirin, Pycnogenol®, ticlopidine, or sulodexide 86
Thrombo-prophylaxis prevents thrombotic events in home-managed COVID patients. A registry study 86
Supplementation with Pycnogenol® improves signs and symptoms of menopausal transition. 85
Pycnogenol® supplementation in minimal cognitive dysfunction 85
Pycnogenol® prevents oxidative stress and side effects in patients with hypothyroidism during levothyroxine treatment 84
PycnoRacer®, a fitness drink including Pycnogenol®, improves recovery and training in the Cooper test 84
Osteoporosis of the jaw. Product evaluation: mf Odontovis Calcium®. 83
Supplementation with Robuvit® in post-mastectomy post-radiation arm lymphedema. 83
[Severe intermittent claudication: PGE1 treatment. A 40-week registry, efficacy and costs]. 82
Keloidal penile fibrosis: improvements with Centellicum® (Centella asiatica) and Pycnogenol® supplementation: a pilot registry 82
Central Cardiovascular Calcifications: Supplementation With Pycnogenol® and Centellicum®: Variations Over 12 Months 82
Anthocran® Phytosome®: Prevention of Recurring Urinary Infections and Symptoms after Catheterization 82
Effects of a curcumin-based supplementation in asymptomatic subjects with low bone density: a preliminary 24-week supplement study 81
Assessment of ultrasound acoustic artifacts in patients with acute dyspnea: a multicenter study 81
Improved management of primary chronic fatigue syndrome with the supplement French oak wood extract (Robuvit®): a pilot, registry evaluation. 79
Pycnogenol® improvements in asthma management. 79
Pulmonary nodule. 78
Pleural disease 78
Thoracic ultrasound in children: evidence and drawbacks 77
Transthoracic ultrasound in the assessment of pleural and pulmonary diseases: Use and limitations 77
Xerostomia: prevention with Pycnogenol® supplementation: a pilot study. 77
Potential role of curcumin phytosome (Meriva) in controlling the evolution of diabetic microangiopathy. A pilot study. 76
Gore external valve support for superficial saphenous vein incompetence: a 10-year, follow-up registry. 76
A sport cream (Harpago-Boswellia-ginger-escin) for localized neck/shoulder pain 76
Supplementation with high titer cranberry extract (Anthocran®) for the prevention of recurrent urinary tract infections in elderly men suffering from moderate prostatic hyperplasia: a pilot study 75
Pycnogenol®-Centellicum® supplementation improves lung fibrosis and Post-Covid-19 lung healing 75
Osteoporosis of the jaw. Product evaluation: mf Odontovis Calcium®. 74
Prevention of post thrombotic syndrome with Pycnogenol® in a twelve month study. 74
Movardol® (N-acetylglucosamine, Boswellia serrata, ginger) supplementation in the management of knee osteoarthritis: preliminary results from a 6-month registry study 74
Ocular and optic nerve ischemia: recognition and treatment with intravenous prostaglandin E1. 73
Totale 10.259
Categoria #
all - tutte 47.911
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.911


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021305 0 0 0 0 0 146 22 14 28 37 28 30
2021/2022664 25 19 10 102 75 38 20 49 37 22 73 194
2022/20231.889 182 272 93 201 165 360 116 155 210 25 74 36
2023/20241.020 57 40 75 34 58 227 252 54 43 58 34 88
2024/20252.625 164 535 420 76 102 103 47 142 358 139 216 323
2025/20262.350 329 181 571 742 460 67 0 0 0 0 0 0
Totale 12.007